25B-NAcPip

Other namesN-(Piperidin-1-ylcarbonylmethyl)-4-bromo-2,5-dimethoxyphenethylamine

ATC code

• None

Legal status

• In general Unscheduled

PubChem CID

• 169777235

25B-NAcPip

Clinical data
Other names	N-(Piperidin-1-ylcarbonylmethyl)-4-bromo-2,5-dimethoxyphenethylamine
ATC code	None
Legal status
Legal status	In general Unscheduled
Identifiers
IUPAC name 2-{[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino}-1-(piperidin-1-yl)ethan-1-one
PubChem CID	169777235
Chemical and physical data
Formula	C17H25BrN2O3
Molar mass	385.302 g·mol−1
3D model (JSmol)	Interactive image
SMILES COc1cc(Br)c(cc1CCNCC(=O)N1CCCCC1)OC
InChI InChI=1S/C17H25BrN2O3/c1-22-15-11-14(18)16(23-2)10-13(15)6-7-19-12-17(21)20-8-4-3-5-9-20/h10-11,19H,3-9,12H2,1-2H3 Key:NPHDUYTXALMKMJ-UHFFFAOYSA-N

25B-NAcPip is a chemical compound related to the 25-NB family of psychedelic drugs.^[1][2][3] It has been described in patents published by psychedelic pharmaceutical companies like Betterlife Pharma and Mindstate Design Labs.^[1][2] Uniquely among 25-NB compounds, 25B-NAcPip is similar to simplified/partial lysergamides and has elements of the chemical structure of LSD and related psychedelic lysergamides like LSD-Pip within its structure.^[3] 25B-NAcPip may or may not be a controlled substance in Canada as of 2025.^[4]